Amicus Therapeutics Inc (NASDAQ:FOLD)

8.81
Delayed Data
As of Jul 23
 +0.07 / +0.80%
Today’s Change
8.60
Today|||52-Week Range
25.39
-61.84%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 14.50, with a high estimate of 29.00 and a low estimate of 12.00. The median estimate represents a +64.59% increase from the last price of 8.81.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Hold stock in Amicus Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$73.0M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.09%
 
 
 
 
 
 
Growthannually 18.38%
 
 
 
 
 
 

Sales

Growthquarterly 9.88%
 
 
 
 
 
 
Growthannually 17.73%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.